SurModics

Yahoo Finance • 2 months ago

Surmodics Inc (NASDAQ:SRDX) Beats Q3 Earnings Estimates Despite Revenue Challenges, Raises Full-Year Guidance

SURMODICS INC (NASDAQ:SRDX [https://www.chartmill.com/stock/quote/SRDX/profile]) REPORTS Q3 EARNINGS BEAT AMID MIXED REVENUE PERFORMANCE Surmodics Inc, a provider of medical device and in vitro diagnostic technologies, posted better-than-... Full story

Yahoo Finance • 2 months ago

Surmodics jumps amid pre-trial hearing in FTC's suit to block sale to GTCR

[Judge with paper document pronouncing sentence in a court of law.] Dmytro Skrypnykov/iStock via Getty Images Surmodics (SRX) rose 12% amid a pre-trial hearing in the Federal Trade Commission's lawsuit to block GTCR's purchase of Surmodic... Full story

Yahoo Finance • 3 months ago

Surmodics reports June cyber incident, restores critical IT systems

Surmodics, Inc. (NASDAQ:SRDX), a medical technology company with a market capitalization of $419 million, reported Wednesday that it experienced a cybersecurity incident on June 5, when an unauthorized third party gained access to certain... Full story

Yahoo Finance • 2 years ago

Returns Are Gaining Momentum At Surmodics (NASDAQ:SRDX)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (R... Full story

Yahoo Finance • 2 years ago

Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28

EDEN PRAIRIE, Minn., November 14, 2023--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate... Full story

Yahoo Finance • 2 years ago

KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer

MAHWAH, N.J., June 27, 2023--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative... Full story

Yahoo Finance • 2 years ago

Why Shares of Surmodics Soared on Tuesday

Shares of Surmodics (NASDAQ: SRDX) were up 16% early Tuesday afternoon as the healthcare company, which provides chemicals for in vitro diagnostic immunoassay tests and makes coatings for intravascular medical devices, got an upgraded rati... Full story

Yahoo Finance • 2 years ago

Surmodics, Inc. (NASDAQ:SRDX) Q2 2023 Earnings Call Transcript

Surmodics, Inc. (NASDAQ:SRDX) Q2 2023 Earnings Call Transcript April 26, 2023 Surmodics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.51. Operator: Welcome everyone to Surmodics’ Second Quarter and Fisca... Full story

Yahoo Finance • 3 years ago

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX

NEW YORK, March 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASDAQ: SRDX) resulting from allegatio... Full story

Yahoo Finance • 3 years ago

ROSEN, A TOP RANKED LAW FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX

NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASDAQ: SRDX) resulting from allegati... Full story

Yahoo Finance • 3 years ago

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX

NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASDAQ: SRDX) resulting from allegati... Full story

Yahoo Finance • 3 years ago

Surmodics to Participate in Upcoming Investor Conferences in March

EDEN PRAIRIE, Minn., March 08, 2023--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in... Full story

Yahoo Finance • 3 years ago

SRDX NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX

NEW YORK, March 03, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASDAQ: SRDX) resulting from allegati... Full story

Yahoo Finance • 3 years ago

全球知名投資者律師事務所 ROSEN 鼓勵 Surmodics Inc. 的投資者諮詢證券集體訴訟調查情況 - SRDX

紐約, Feb. 25, 2023 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律師事務所 Rosen Law Firm 繼續代表 Surmodics Inc. (NASDAQ: SRDX) 的股東進行潛在的證券索賠調查，原因是有指控稱 Surmodics 可能向投資大眾發布了具有重大誤導性的商業資訊。 這意味著什麼：如果您購買了 Surmodics 公司的證券，您可能有權獲得賠償，透過勝訴分成協議而毋須支付任何自付費用或開支。Rosen Law Fi... Full story

Yahoo Finance • 3 years ago

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX

NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASDAQ: SRDX) resulting from allegation... Full story

Yahoo Finance • 3 years ago

NATIONALLY RANKED ROSEN LAW FIRM Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX

NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASDAQ: SRDX) resulting from allegatio... Full story

Yahoo Finance • 3 years ago

Surmodics, Inc: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Surmodics, Inc (“Surmodics” or “the Company”) (NASDAQ: SRDX) investors... Full story